Purchase Order 75N95024P00323
- Not listed
- This is a federal contract award to 10X Genomics, Inc., a biotechnology company specializing in advanced genomic analysis platforms and reagents. The U.S. National Institute on Aging (NIA), a civilian agency within the National Institutes of Health (NIH), awarded this $249,991.40 firm fixed-price delivery order for the procurement of Chromium Next GEM Single Cell Multiome and GEM-X Single Cell 5 kits, related indexes, and chips. This delivery order is part of a larger indefinite delivery...
- This federal contract award is between the National Institute on Aging (NIA), a civilian agency within the U.S. government, and 10X Genomics, Inc., a biotechnology company specializing in advanced genomic analysis platforms and research tools. The $23,171.17 firm fixed-price delivery order is for the provision of Chromium GEM-X Single Cell Kits and GEM-X Universal Samples, which are biological and reagent materials used in single-cell analysis research. The award is part of a larger $7,000,000...
- This federal contract award is for the delivery of Chromium Next GEM Single Cell ATAC, Kit TT, and Kit N Set A kits from 10X Genomics, Inc., a life sciences technology company that specializes in single-cell and spatial analysis products and services. The $236,944.00 firm fixed price delivery order contract was awarded by the National Institute on Aging, a civilian agency within the National Institutes of Health (NIH) under the Department of Health and Human Services. The contract aims to supply...
- This is a federal contract award from the National Institute on Aging (NIA), a component of the National Institutes of Health (NIH), to 10X Genomics, Inc., a biotechnology company specializing in advanced genomic analysis platforms and reagents. The $174,028.50 contract is for the delivery of single-cell and single nucleus kits, which are used in single-cell and spatial transcriptomics research to support biomedical investigations into areas such as infectious diseases, cancer, neurological...
- This firm fixed price delivery order contract, awarded to 10X Genomics, Inc. by the National Institute on Aging (NIA), a component of the National Institutes of Health (NIH), provides specialized biological and reagent materials. Specifically, the contract covers the purchase of Chromium Next GEM Single Cell ATAC, Chip-Seq, and Kit and Assay Set A Kits. The total ceiling value of the contract is $12,968.00, with a period of performance extending to August 30, 2029. 10X Genomics is the prime...
- This is a federal contract award to 10X Genomics, Inc., a life sciences technology company, by the National Institute on Aging (NIA), which is part of the National Institutes of Health (NIH). The $59,963.76 firm fixed price contract provides the NIA's Laboratory of Molecular Biology and Immunology (LMBI) with the Chromium Next GEM Single Cell Multiome ATAC + Gene Expression Reagent Bundle and the Chromium Next GEM Single Cell ATAC Library & Gel Bead Kit v1.1. These specialized kits enable...
- This is a firm fixed price delivery order contract awarded by the National Institute on Aging (NIA), a component of the U.S. Department of Health and Human Services (HHS), to 10X Genomics, Inc. The contract, valued at $15,279.40, is for the provision of Chromium Next GEM Single Cell Kits, CRISPR Kits, and Chromium Next GEM Chip N Single Cell Kits. These products are specialized reagents and materials used for single-cell RNA sequencing, single-cell ATAC sequencing, and spatial transcriptomics...
- This is a firm fixed-price delivery order contract awarded by the National Institute on Aging (NIA), a civilian agency within the National Institutes of Health (NIH), to 10X Genomics, Inc., a biotechnology company specializing in advanced genomic analysis platforms and reagents. The contract, valued at $97,599.20, is for the provision of various products related to single-cell and spatial transcriptomics research, including Chromium Nuclei Isolation Kits, GEM-X Universal 3' Gene Expression V4...
- This is a firm fixed price delivery order contract awarded by the National Institute on Aging (NIA), a civilian agency within the National Institutes of Health (NIH), to 10X Genomics, Inc., a life sciences technology company. The contract is for the provision of Chromium Next GEM Single Cell Multiome ATAC + Gene Expression Reagent Bundles, which support single-cell RNA sequencing, single-cell ATAC sequencing, and multi-omics analysis research. The contract has a ceiling value of $76,646.17 and a...
- This federal contract award was made by the National Institute on Aging (NIA), a civilian agency under the Department of Health and Human Services (HHS), to the prime contractor 10X Genomics, Inc. The $14,446.50 fixed-price delivery order contract is for the provision of LABORATORY SUPPLIES - GEM-X CHROMIUM CELL KITS. 10X Genomics, a for-profit manufacturer of life sciences products and services, will deliver these single-cell analysis kits to support the NIA's biomedical research efforts,...
This federal contract award, valued at $249,990.00, was issued by the National Institute on Aging (NIA), a component of the National Institutes of Health (NIH) under the Department of Health and Human Services. The prime contractor is 10X Genomics, Inc., a life sciences technology company that specializes in products and services for single-cell and spatial analysis applications. The award is for the delivery of six (6) Chromium Next GEM Single Cell Multiome ATAC and Gene Expression Reagent Bundles, 16 reactions each, as well as one (1) Chromium Gem-C Single Cell 3' Kit v4, 16 reactions. These specialized reagent kits and platforms enable high-throughput genomic analysis at the single cell level, supporting biomedical research efforts. The contract does not utilize a set-aside designation and has a firm fixed price structure with a completion date of September 10, 2024. This award is part of a larger indefinite delivery contract between 10X Genomics and the NIH's National Institute of Neurological Disorders and Stroke, valued at up to $750,000, for the provision of optimization tools to further research into neurological diseases and disorders.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $250.0k | 6/13/24 |